Skip to content
Screener

Pre-Tax Income at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$6.75B+3.9%
AbbVie logo
AbbVieABBV
$4.28B+175%
IAR
Integra LifeSciencesIART
$4.74M+101%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$15M-5.4%
MiMedx Group logo
MiMedx GroupMDXG
-$17.78M-237%
AIR
AirSculpt Technologies, Inc.AIRS
-$1.21M-56.3%

Other financials

Income statement

See full
Revenue$67.5M+31.7%
Gross profit$47.7M+35.3%
Operating income-$4.3M+69.6%
Net income-$11.7M+29.2%
EPS (diluted)-$0.39+31.6%

Balance sheet

See full
Cash & equivalents$71.2M+30.2%
Total debt$263.7M+14.1%
Total equity$21.6M-5.1%
Total assets$351.9M+6.8%

Cash flow

See full
Operating cash flow-$16.6M+11.5%
CapEx$3.7M+125%
Free cash flow-$20.3M+0.6%

Valuation

See full
Market cap$2.24B+130%
Enterprise value$2.43B+111%
P/S9.1×+3.6×

Profitability

See full
Gross margin70.5%+3.3pp
Operating margin-7.6%-3.4pp
Net margin-15.8%-6.4pp
FCF margin-16.9%-6.4pp

Returns & leverage

See full
Return on equity-175.3%-43.4pp
Debt / equity12.2×+2.1×
Current ratio3.8×+1.0×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The source filing: Establishment Labs’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001688757-26-000050
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income369162341
Interest expense7,0345,95614,12211,809
Other (income) loss, net454(4,383)(25)(7,136)
Loss before income taxes(11,742)(15,589)(24,836)(35,385)
Provision for income taxes61,0042941,918
Net loss$(11,748)$(16,593)$(25,130)$(37,303)
Basic and diluted net loss per share$(0.39)$(0.57)$(0.84)$(1.29)
Weighted average outstanding shares used for basic and diluted net loss per share30,121,68528,913,81130,037,82628,882,108

Item 1. Financial Statements - Unaudited

FAQ

What is Establishment Labs's pre-tax income?
Establishment Labs (ESTA) reported pre-tax income of -$11.74M in Q2 2026.
How has Establishment Labs's pre-tax income changed year-over-year?
Establishment Labs's pre-tax income increased by 24.7% year-over-year, from -$15.59M to -$11.74M.
What is the long-term trend for Establishment Labs's pre-tax income?
Over 4 years (2021 to 2025), Establishment Labs's pre-tax income has grown at a 9.9% compound annual growth rate (CAGR), from -$39.71M to -$58.02M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.

Ask your AI about Establishment Labs's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude